Showing results (41-50 of 156) with videos related to
Sort By:
Pageof 16
Human Reproduction (Oxford, England)|February 7, 2001
Unilateral renal agenesis associated with congenital bilateral absence of the vas deferens: phenotypic findings and genetic considerationsT McCallum, J Milunsky, R Munarriz, et al.Heliyon|January 12, 2018
The effect of light touch on balance control during overground walking in healthy young adultsA R Oates, J Unger, C M Arnold, et al.Human Movement Science|June 7, 2019
Are there attentional demands associated with haptic modalities while walking in young, healthy adults?Aaron P Awdhan, Mackenzie D Bone, Joel L Lanovaz, et al.Movement Disorders : Official Journal of the Movement Disorder Society|September 13, 2008
Control of dynamic stability during gait termination on a slippery surface in Parkinson's diseaseAlison R Oates, Jim S Frank, Aftab E Patla, et al.Human Movement Science|July 22, 2019
Comparing the effect of haptic modalities on walking balance control: Is using one or two arms better?Alison R Oates, Abhishek Kumar, Wyatt Cowell, et al.Journal of the National Cancer Institute|May 20, 1998
Kirsten ras mutations in patients with colorectal cancer: the multicenter "RASCAL" studyH J Andreyev, A R Norman, D Cunningham, et al.Sociological Spectrum : the Official Journal of the Mid-South Sociological Association|July 2, 2020
Using photovoice to explore social determinants of obesity in two underserved communities in the southeastLori Brand Bateman, Zachary R Simoni, Gabriela R Oates, et al.Gait & Posture|October 4, 2016
Validation of a commercial inertial sensor system for spatiotemporal gait measurements in childrenJoel L Lanovaz, Alison R Oates, Tanner T Treen, et al.American Journal of Health Behavior|February 6, 2020
Social Risk Factors for Medication Nonadherence: Findings from the CARDIA StudyGabriela R Oates, Lucia D Juarez, Barbara Hansen, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 7, 2020
Tobacco smoke exposure limits the therapeutic benefit of tezacaftor/ivacaftor in pediatric patients with cystic fibrosisElizabeth Baker, William T Harris, Steven M Rowe, et al.Pageof 16